Exos TFP Holdings’s Medtronic MDT Stock Holding History

Exos TFP Holdings’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-9,228	Closed	-$745K	–	594
2022 Q3	$745K	Buy	+9,228	New	+$829K	0.34%	89

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Exos TFP Holdings's MDT Position: Q4 2022 in Review

Exos TFP Holdings sold out of Medtronic (MDT) in Q4 2022, closing a stake of 9,228 shares — an estimated $745K sold.

Exos TFP Holdings first reported a position in MDT in Q3 2022 and held it in 1 quarter. The position peaked at $745K in Q3 2022. 1,961 funds tracked by Wall St. Rank hold MDT as of Q4 2022.

Exos TFP Holdings reported no remaining Medtronic position as of Q4 2022 after selling out during the quarter.
Exos TFP Holdings sold 9,228 Medtronic shares in Q4 2022, an estimated $745K.
Exos TFP Holdings first reported a position in Medtronic in Q3 2022 and held it in 1 quarter.
Exos TFP Holdings's Medtronic position peaked at $745K in Q3 2022.
1,961 funds tracked by Wall St. Rank held Medtronic as of Q4 2022.

Based on Exos TFP Holdings's 13F filing for Q4 2022, filed 10 Feb 2023.